Tag: Erionota thrax
International news in brief – January/February 2015
Germany : Bayer to divest equine assets to Merial Bayer HealthCare has entered into a definitive agreement to sell its equine products Legend®/Hyonate® (hyaluronate sodium) and Marquis® (ponazuril) to Merial, Inc.The deal is expected to close in the first quarter 2015 subject to customary conditions, including relevant merger control clearance. “This transactionwill allow our business […]
